Onychomycosis in Immunosuppressed Children Receiving Chemotherapy
Article first published online: 29 OCT 2012
© 2012 Wiley Periodicals, Inc.
Volume 31, Issue 5, pages 618–620, September/October 2014
How to Cite
García-Romero, M. T., Aguilar, E. L. and Arenas, R. (2014), Onychomycosis in Immunosuppressed Children Receiving Chemotherapy. Pediatric Dermatology, 31: 618–620. doi: 10.1111/pde.12030
- Issue published online: 4 SEP 2014
- Article first published online: 29 OCT 2012
Vol. 31, Issue 6, 759, Article first published online: 25 NOV 2014
Onychomycosis in children has a low incidence worldwide; certain conditions such as immunosuppression have been described as risk factors for it. We studied 72 children receiving chemotherapy for different neoplasms to determine the frequency of onychomycosis. Only one patient had white superficial onychomycosis from Trichophyton rubrum, a frequency of 1.3%, not different from that reported in healthy patients.